PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q1–2025Q4) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close
Uni-Chem, a natural leather supplier for automotive seats, posted widening losses in H1 2026 due to automaker production disruptions, while pursuing a business transformation through the acquisition of US flexible-electronics firm Loomia Technologies to enter the robotic e-skin market.
2025 revenue rose sharply to KRW 106.2bn year-on-year and the operating loss narrowed, but the company posted its third consecutive year of net losses attributable to owners.
In H1 2026, despite a revenue recovery, losses actually widened due to Hyundai and Kia vehicle production disruptions.
Following the acquisition of the KG Trust Hwaseong plant, the company decided to acquire 100% of US-based Loomia Technologies, entering the robotic e-skin and smart leather business.
The debt ratio improved markedly from 212.5% in 2022 to 72.7% in 2025, indicating a more stable capital structure.
Management has set a target of an H2 earnings recovery and full-year operating profit turnaround, but this remains a plan, and the Loomia acquisition process is still ongoing.
Founded in 1976, Uni-Chem is a leather specialist producing natural leather for automotive seats and fashion leather for handbags. Its key automotive customers are Hyundai Motor and Kia, supplying natural leather seats for core models such as the Grandeur and Palisade.
Its major clients include Coach, Tumi, and Hyundai and Kia. The company recently built an integrated production system covering post-processing and sewing of automotive interior materials through the acquisition of the KG Trust Hwaseong plant.
In addition, it announced a decision to acquire 100% of Loomia Technologies, a flexible-electronics deep-tech firm headquartered in Brooklyn, New York, for a consideration of KRW 8.574bn, equivalent to 6.48% of shareholders' equity.
Loomia holds the proprietary LEL technology, an ultra-thin electronic circuit structure that can be embedded inside leather or textiles. Loomia is also a member of HAND ERC, a tactile-sensing consortium that includes Meta and Amazon Robotics as industry members.
In the automotive segment, Loomia was selected as a seat-heating system supplier for the Volkswagen Group's ecosystem vehicle program through global seat and components maker Sabelt.
Through this deal, Uni-Chem is expanding from an automotive-interior-centered business into robotics, rail, and aerospace B2B areas while restructuring its portfolio toward next-generation materials such as smart leather based on flexible-electronics technology.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩30.9B | ₩500M | 1.5% |
| 2025Q3 | — | — | — |
| 2025Q4 | ₩20.1B | -₩2.7B | −13.5% |
| 2026Q1 | ₩19.6B | -₩1.2B | −6.3% |
| 2026Q2 | ₩31B | -₩2.9B | −9.5% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩120.4B | ₩3.3B | ₩2.4B | 2.7% | 1.9% | 212.5% |
| 2023 | ₩108.3B | ₩4.7B | -₩6.3B | 4.4% | −4.3% | 50.8% |
| 2024 | ₩68.2B | -₩6.3B | -₩10.2B | −9.2% | −8.5% | 54.4% |
| 2025 | ₩106.2B | -₩600M | -₩6.6B | −0.5% | −5.0% | 72.7% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-04
Consolidated revenue in 2025 rose sharply to KRW 106.24bn from KRW 68.22bn in 2024. The operating result was a loss of KRW 0.57bn (operating margin -0.5%) in 2025, a marked narrowing from an operating loss of KRW 6.27bn (margin -9.2%) in 2024.
Net loss attributable to owners was KRW 6.56bn in 2025, smaller than the KRW 10.23bn loss in 2024, but combined with the KRW 6.25bn loss in 2023, this marks a third consecutive year of net losses.
In 2023, the company posted an operating profit of KRW 4.74bn (margin 4.4%) yet still recorded a net loss of KRW 6.25bn, implying losses stemmed from non-operating items. 2022 had the highest revenue of the four years at KRW 120.44bn, with an operating profit of KRW 3.27bn and a net profit attributable to owners of KRW 2.35bn, although the debt ratio stood at a high 212.5% at the time.
By quarter, Q2 2025 revenue was KRW 30.87bn with an operating profit of KRW 0.46bn, but Q4 2025 reverted to a loss with revenue of KRW 20.06bn and an operating loss of KRW 2.72bn.
Losses continued into 2026, with Q1 revenue of KRW 19.56bn, an operating loss of KRW 1.24bn and a net loss of KRW 2.71bn, while Q2 revenue recovered to KRW 30.96bn — roughly the year-earlier level — yet the operating loss widened to KRW 2.93bn and the net loss to KRW 3.60bn.
Operating cash flow also swung sharply, from +KRW 23.43bn in 2022 to -KRW 16.86bn in 2023, +KRW 3.70bn in 2024, and -KRW 8.57bn in 2025. This pattern broadly aligns with the company's explanation of revenue deferral caused by automaker production disruptions.
Uni-Chem's core revenue comes from natural leather seats for automotive interiors, closely tied to vehicle production volumes. In H1 2026, sales in North America of the 2026 Palisade were temporarily halted due to a safety issue, and a major fire at a Daejeon-based engine-valve supplier disrupted engine supply.
As a result, production of the Grandeur and Palisade — Uni-Chem's core applied models — declined, cutting related revenue by roughly 40%, though the company argues this does not reflect a structural demand decline.
Meanwhile, in vehicle interiors, the concept of 'smart surfaces' is gaining traction alongside the software-defined vehicle trend; according to Global Market Insights, the automotive smart-surface market is projected to grow from roughly USD 9.5bn in 2024 to about USD 88.4bn by 2034.
In robotics, demand for tactile sensors and e-skin technology is emerging alongside expectations for humanoid commercialization; Loomia is a member of HAND ERC, a consortium including Meta and Amazon Robotics as industry members, aimed at advancing robotic tactile-sensing technology.
Among domestic leather processors, few have Uni-Chem's track record as a Tier-1 vendor supplying natural leather seats to Hyundai and Kia, but the e-skin and flexible-electronics field remains at an early stage with a fluid competitive landscape. Raw hides are entirely imported, exposing the business to currency and global commodity price fluctuations.
CEO Lee Jong-wan stated that the H1 earnings weakness was largely driven by external factors that disrupted automaker production, and that annual order volumes were unchanged, allowing for a swift recovery from H2.
He said production and sales had returned to normal levels from mid-June and the plant was operating on a 24-hour production system, targeting the company's highest-ever consolidated revenue and a full-year operating profit turnaround.
In August 2026, Uni-Chem disclosed a decision to acquire 100% of Loomia Technologies, a US flexible-electronics deep-tech company, for a consideration of KRW 8.574bn, equal to 6.48% of shareholders' equity.
The consideration is to be paid through a combination of cash, treasury shares, and a performance-based (earn-out) convertible bond.
According to a report by The Robot Report, Uni-Chem agreed to acquire 100% of Loomia for up to USD 6 million and plans to complete the equity-acquisition process by January 4 of next year (a provisional schedule, pending final disclosure).
The CEO said the company is in discussions with global automotive and robotics firms on technology development collaboration and is also seeking strategic investment from a major domestic partner.
In commercialization, the strategy prioritizes outsourced production infrastructure over large-scale in-house capital investment to reduce OPEX and CAPEX burden, targeting the domestic, Northeast Asian, and North American markets first.
Through this, the company aims to generate visible revenue from smart leather and robotic e-skin from 2027 onward.
Uni-Chem's shares trade at a discount to net asset value, with both the self-calculated and KRX official metrics indicating a price below book value per share.
Given three consecutive years of net losses attributable to owners from 2023 through 2025, conventional price-to-earnings comparisons are difficult to apply at this stage. The debt ratio's decline from 212.5% in 2022 to 72.7% in 2025 reflects a stabilizing capital structure, which may somewhat ease valuation concerns.
The company has not paid dividends recently, so shareholder returns are less relevant than the pace of core-business recovery and progress in new businesses as the key variables to watch.
Ultimately, the current valuation level can be interpreted differently depending on the speed of recovery in the automotive end market and the extent to which the Loomia-driven new business becomes tangible.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-04
The company attributes H1 weakness to temporary automaker production disruptions and expects deferred order volumes to be concentrated in H2. It also cites the normalization of production and sales from mid-June and a 24-hour production system as supporting evidence.
Based on this, management has set targets for record annual revenue and a full-year operating profit turnaround.
Through the Loomia Technologies acquisition, the company is expanding from an automotive-interior-centered business into e-skin markets for robotics, medical, and defense applications.
Loomia's membership in the HAND ERC consortium, which includes Meta and Amazon Robotics, is seen as providing access to a relevant ecosystem. Synergies with existing automotive channels are also expected, as illustrated by the seat-heating supply case for the Volkswagen Group's vehicle program.
The debt ratio fell sharply from 212.5% in 2022 to 72.7% in 2025, reflecting a stabilizing capital structure. Internalizing post-processing and covering operations, along with expanding new B2B orders, is also seen as contributing to profitability improvement. Whether this improvement continues will require confirmation from upcoming quarterly results.
The company posted net losses attributable to owners in all three years from 2023 to 2025, and losses actually widened in Q1 and Q2 2026 despite a revenue recovery. Q2 2026 revenue returned to roughly the year-earlier level, yet both the operating loss and net loss increased from the prior quarter.
This suggests a cost structure burden that prevents revenue growth from translating directly into profit improvement.
The H1 2026 earnings weakness was triggered by external factors including a North American sales suspension and a fire at a domestic supplier. Given the high revenue dependence on specific automotive models and customers, similar production disruptions could shake earnings again. While diversification is underway, the automotive segment remains the core of the business.
The Loomia-driven e-skin and smart leather business is itself projected by management to generate visible revenue only from 2027 onward, making a near-term earnings contribution unlikely.
Because part of the acquisition consideration is to be paid via a performance-based (earn-out) convertible bond, there is potential for share dilution once conditions are met. The timeline for completing the acquisition process also remains at a provisional stage, not yet finalized.
Revenue is directly exposed to external variables such as automaker production plans, recalls, and supplier issues. In H1 2026, a North American sales suspension and a fire at a domestic supplier reduced production of core models and affected revenue. The possibility of similar supply-chain issues recurring cannot be ruled out.
Operating cash flow swung from +KRW 23.4bn in 2022 to -KRW 16.9bn in 2023, +KRW 3.7bn in 2024, and -KRW 8.6bn in 2025, showing an unstable pattern. Amid continued net losses, additional funding needs may arise from new-business investments such as the Loomia acquisition.
While the financial structure has improved via a lower debt ratio, the burden could increase again if profitability recovery is delayed.
The Loomia acquisition is still in the process of equity acquisition of another company, with only a provisional completion timeline reported and no final disclosure yet.
There are risks of share dilution from the earn-out CB issuance and of technology/organizational integration challenges during post-merger integration. The e-skin and smart-leather markets themselves are also still at an early stage, so the pace of commercialization may differ from plan.
Q3 2026 preliminary earnings disclosure — a point to check whether the H2 earnings recovery management guided for is actually materializing.
Per a Robot Report article (August 2026), the planned deadline for completing the Loomia equity-acquisition process — actual completion disclosure and final acquisition terms need confirmation.
FY2026 annual business report and confirmed consolidated results — a point to check whether management's targets of record annual revenue and full-year operating profit turnaround were achieved.
Monitor disclosures on earn-out CB issuance terms, conversion price, and dilution scale — key information for gauging the degree of share dilution.
Follow-up disclosures on joint-development discussions with global automotive and robotics firms and on strategic investment from a major domestic partner.
Uni-Chem is at a transition point, moving from a traditional leather manufacturer focused on automotive seat leather toward a robotic e-skin and smart-material company through the acquisition of the KG Trust Hwaseong plant and the Loomia Technologies deal.
Consolidated revenue rose sharply in 2025 and the operating loss narrowed, but the company has yet to stabilize profitability, having posted net losses attributable to owners for three consecutive years.
In H1 2026, both revenue and profit were pressured by external factors in the automotive end market — a North American sales suspension and a domestic supplier fire — and losses actually widened even as Q2 revenue recovered to roughly the year-earlier level.
Management cites deferred order volumes and normalized production as the basis for its target of a significant H2 earnings improvement and a full-year profit turnaround, but this remains a plan and forecast rather than a confirmed outcome.
The Loomia acquisition offers an opportunity to expand into robotics, medical, and defense applications, but with the process still ongoing and visible revenue not expected until 2027 or later, it will take time for results to materialize.
Improvement in the debt ratio is a positive signal for financial stability, but the large swings in operating cash flow and the potential for share dilution tied to the new business are variables that warrant continued attention.
Investors should track, in sequence, the confirmed H2 and full-year results, the completion and terms of the Loomia acquisition, and the timing of any tangible revenue contribution from the new business.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.